Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study
Publication Type:
Journal Article
Authors:
Osinusi, A.;
Kohli, A.;
Marti, M.M.;
Nelson, A.;
Zhang, X.;
Meissner, E.G.;
Silk, R.;
Townsend, K.;
Pang, P.S.;
Subramanian, G.M.;
J G McHutchison;
Fauci, A.S.;
Masur, H.;
Kottilil, S.Source:
Ann Intern Med, Volume 161, Issue 9, p.634-638 (2014)
Keywords:
chronic HCV,
Creatinine,
Disease,
Genotype,
genotype 1,
HCV,
Health,
hepatitis,
Hepatitis C,
hepatitis C virus,
Hypercholesterolemia,
Hypophosphatemia,
Infection,
interferon,
Liver,
Mutation,
Patients,
Renal,
Renal Insufficiency,
Retreatment,
Ribavirin,
Rna,
Safety,
Sample Size,
Serum,
sofosbuvir,
strategies,
sustained virologic response,
therapy,
treatment
